Countries are eligible to enter or leave the LDC category if they meet the defined inclusion or graduation thresholds of the criteria. The graduation thresholds are set higher than the thresholds ...

Objective Sorafenib is effective in hepatocellular carcinoma (HCC), but patients ultimately present disease progression. Molecular mechanisms underlying acquired resistance are still unknown. Herein, ...

Aiming at a clinical characterization of patients with HCC in NCL, a retrospective analysis ... for the two staging systems (CLIP score and BCLC score) that are influenced by several of the ...

The Barcelona Clinic Liver Cancer (BCLC) stage (Gini index ... with the Declaration of Helsinki. The inclusion criteria were as follows: 1) 18 years or older with the definite diagnosis of HCC; 2) ...

Objective Hepatocellular carcinoma (HCC) is an aggressive malignancy with limited effective treatment options. An alternative strategy is to target cells, such as tumour-infiltrating macrophages, in ...

In the present study, it was found that young HCC patients had different etiologies from older HCC patients. As patient age increased, positivity for anti-HCV increased, which was consistent with ...

A cancer patient who is undergoing treatment and had a toe removed says the blue badge system is letting people like her down. Finance worker Sandy Burr was diagnosed with melanoma skin cancer in ...

Video content above is prompted by the following: Please briefly review the treatment options for patients with hepatocellular carcinoma (HCC) confined to the liver but unresectable according to NCCN ...

Among 215 patients with a non-metastatic HCC diagnosis ... Liver 2018 criteria for non-invasive imaging-based diagnosis in cirrhosis or histological confirmation and had to have BCLC stage A ...

have Barcelona Clinic Liver Cancer (BCLC) stage B or C HCC, an ECOG performance status of 0 or 1, a Child-Pugh score of A to B7, and a life expectancy of at least 3 months. Exclusion criteria across ...